In the first quarter of 2026, UNI MEDICAL (02666) saw an approximately 4.8% year-on-year increase in net profit attributable to ordinary shareholders.

UNI MEDICAL (02666) announced that in the first quarter of 2026, the overall operation of the group was stable and improving, and various key works have achieved positive results. As of March 31, 2026, the group's income decreased by about 4.5% compared to the same period last year, mainly due to a decrease in financial business income. However, the net profit for the period increased by about 5.2% compared to the same period last year, benefiting from optimized fund cost control and reduced costs related to medical business. The net profit attributable to ordinary shareholders for the period increased by about 4.8% compared to the same period last year. In terms of comprehensive healthcare business, the group actively responded to the healthcare payment reform, continuously strengthened the development of "integrated, differentiated, specialized, intelligent, and lean" services, and improved capability building in disciplines, research and innovation, talent cultivation, environment and service improvement. The group's healthcare institutions performed well in the first quarter of 2026, with the addition of 3 provincial-level clinical key specialties, bringing the total number of provincial and above key specialties to 26. By developing therapeutic outpatient and non-medical insurance business, implementing non-holiday clinics, extended hours clinics, and expert clinics, the group achieved a 4.5% increase in outpatient and emergency visits compared to the same period last year, with a 13.3% increase in physical examination income. Cost control was enhanced through streamlined service processes, disease management optimization, and focused improvement in high-value diseases. The group's operational efficiency improved, with average length of stay decreasing to 8.9 days and single bed capacity increasing by 2.7% year-on-year. Efforts to control costs were highlighted by a 1.3% decrease in drug costs as a percentage of revenue and a 3.2% decrease in labor costs as a percentage of revenue, strengthening the group's operational resilience. In the specialty medical and health technology sector, the group fostered characteristic business and core capabilities through intrinsic and extrinsic development strategies. Progress has been made in project layout expansion and capability building, with successful mergers and acquisitions projects advancing smoothly. Universal Ophthalmology's flagship hospital in Beijing, equipped with 20 beds and 47 top international equipment, officially opened to gather national experts and provide high-quality treatment plans. The first successful Histotripsy liver cancer treatment in China marks a significant clinical advancement in tumor non-invasive treatment, with the "Non-invasive Sea Sound Plan" public welfare project launching simultaneously, promoting global leading technology for public benefit. UNI MEDICAL Technology Services (Tianjin) Co., Ltd. led the release of the industry's first "Medical Equipment Full Lifecycle Service Standard" group standard and participated in the formulation of the first national standard in the medical equipment maintenance services field in China. This integration of practical experience from serving more than 1600 medical institutions nationwide into the standards signifies a standardized and regulated high-quality development phase in medical equipment management services, demonstrating the model role of state-owned enterprises in standardization construction. The Health Digital Technology Operating Platform won the bid for the "Smart Haidian" project, covering two large tertiary hospitals in Haidian District, Beijing, and supporting the connection and expansion of other medical institutions in the district to inject digital energy into the development of "Healthy Haidian". In the financial business sector, the group continued to focus on medical care, equipment manufacturing, chemical medicine, and specialty industries, solidly promoting financial business transformation and upgrading plans while actively exploring new models of financial integration such as "leasing + full equipment lifecycle management", "leasing + elderly care operation", "leasing + supply chain finance", "leasing + technology introduction + operation" to serve the modern industrial system and central enterprise responsibilities. Universal Global International Financial Leasing (Tianjin) Co., Ltd. successfully landed the first RMB 500 million strategic emerging ESG-linked syndicated loan in Tianjin, while the group's wholly-owned Beijing Small Easy Chain Technology Co., Ltd. was officially established as the group's sole supply chain finance platform, empowering the coordinated development of central enterprise industrial chains. As of March 31, 2026, the group's interest-bearing assets grew steadily from the end of 2025, with stable net interest and net profit spreads compared to the same period last year, overall stable and controllable asset quality, and prudent provision coverage.